首页> 外文期刊>Experimental and therapeutic medicine >MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2/STAT3 signaling pathway in non-small cell lung cancer
【24h】

MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2/STAT3 signaling pathway in non-small cell lung cancer

机译:MicroRNA-449B-3P通过靶向IL-6和通过非小细胞肺癌中的JAK2 / Stat3信号传导途径来抑制上皮 - 间充质转换

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRs) have vital involvement in the advancement of non-small cell lung cancer (NSCLC); however, the methods of action of miR-449b-3p in the disease are yet to be examined. The present study revealed a distinct downregulation of miR-449b-3p in NSCLC tissue, which was related to the clinicopathological characteristics, and may serve as an independent marker for NSCLC prognosis. NSCLC cell epithelial-mesenchymal transition (EMT), metastasis and migration were distinctly controlled in vitro by miR-449b-3p, that was found to directly target interleukin (IL)-6. Additionally, increased IL-6 level could inhibit miR-449b-3p and suppress the effect of EMT in NSCLC cells by inactivating the Janus kinase 2 (JAK2)/STAT3 signaling pathway. In conclusion, the data from the present study demonstrated that IL-6 is targeted by miR-449b-3p, which affects the JAK2/STAT3 signaling pathway, impacting on the development of NSCLC.
机译:MicroRNA(MIRS)对非小细胞肺癌(NSCLC)的进步有重要的参与; 然而,尚未检查疾病中miR-449b-3p的作用方法。 本研究表明,NSCLC组织中的miR-449b-3p的不同下调,与临床病理特征有关,并且可以作为NSCLC预后的独立标志物。 通过MiR-449b-3p在体外明显地控制NSCLC细胞上皮 - 间充质转换(EMT),发现直接靶向白细胞介素(IL)-6。 另外,增加的IL-6水平可以通过灭活Janus激酶2(JAK2)/ Stat3信号传导途径来抑制miR-449b-3p并抑制EMT在NSCLC细胞中的效果。 总之,来自本研究的数据证明IL-6由MIR-449B-3P靶向,影响JAK2 / Stat3信号通路,影响NSCLC的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号